Skip to content
value.today

ChromaCode, Inc.

🇺🇸 Carlsbad, California, USAHealth CareFounded 2012
Total raised
$92 M
4 rounds on record
Latest round
$4 M
Jan 2025
First round on record
Apr 2017
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ChromaCode, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$4 MNo. 4$2 to $10 million

ChromaCode, Inc.: Raise no. 4, Jan 2025

Investors in this round

4 investors had bought by the notice of Feb 5, 2025: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ChromaCode, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Flook · Executive Officer, Director
  • Aditya Rajagopal · Director
  • Justin Klein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Flook, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 5, 2025. Read the notice at the SEC.

equitySEC
Feb 2022$38 MNo. 3$10 to $50 million

ChromaCode, Inc.: Raise no. 3, Feb 2022

Investors in this round

16 investors had bought by the notice of Feb 27, 2023: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ChromaCode, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$38 M of $43 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark McDonough · Executive Officer, Director
  • Aditya Rajagopal · Director
  • Alexander G. Dickinson · Director
  • Carol G. Gallagher · Director
  • Jenny G. Yip · Director
  • Justin G. Klein · Director
  • Kevin G. O'Boyle · Director
  • Pat G. Smerkers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark McDonough, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 27, 2023. Read the notice at the SEC.

equitySEC
Aug 2019$39 MNo. 2$10 to $50 million

ChromaCode, Inc.: Raise no. 2, Aug 2019

Investors in this round

17 investors had bought by the notice of Dec 3, 2020: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ChromaCode, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$39 M of $41 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregory J. Gosch · Executive Officer, Director
  • Lynne C. Rollins · Executive Officer
  • Aditya J. Rajagopal · Director
  • Alexander G. Dickinson · Director
  • Carol C. Gallagher · Director
  • James C. Blair · Director
  • Jenny C. Yip · Director
  • Pat C. Smerkers · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$29,248,305.60 new money; $9,380,046.67 conversion of notes; $15,528.19 upon exercise of warrants”

Signed by Lynne Rollins, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Dec 3, 2020. Read the notice at the SEC.

equitySEC
Apr 2017$12 MNo. 1$10 to $50 million

ChromaCode, Inc.: Raise no. 1, Apr 2017

Investors in this round

9 investors had bought by the notice of Apr 25, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for ChromaCode, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$12 M of $12 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gregory J. Gosch · Executive Officer, Director
  • Lynne J. Rollins · Executive Officer
  • Alexander G. Dickinson · Director
  • Axel Justin Scherer · Director
  • James C. Blair · Director
  • Peter Justin Klein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$11,565,734.60 new money; $459,263.02 conversion of convertible promissory notes”

Signed by Lynne Rollins, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 25, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ChromaCode, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2025).

    SEC Form D · Feb 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2025

That is all the official record says: ChromaCode, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in ChromaCode, Inc.
InvestorKindAmountRoundRoleSource
T. Rowe Price Health Sciences Fund, Inc.Fund or asset managernot statednot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
T. Rowe Price Health Sciences PortfolioFund or asset managernot statednot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ChromaCode, Inc.
NameRoleNamed in
Paul FlookExecutive officerFeb 2025
Mark McDonoughExecutive officerFeb 2023
Alexander G. DickinsonExecutive officerMar 2022
Vikram C. LambdaExecutive officerMar 2022
Gregory J. GoschExecutive officerDec 2020
Lynne C. RollinsExecutive officerDec 2020
Lynne J. RollinsExecutive officerApr 2017
Aditya RajagopalDirectorFeb 2025
Justin KleinDirectorFeb 2025
Paul FlookDirectorFeb 2025
Alexander G. DickinsonDirectorFeb 2023
Carol G. GallagherDirectorFeb 2023
Jenny G. YipDirectorFeb 2023
Justin G. KleinDirectorFeb 2023
Kevin G. O'BoyleDirectorFeb 2023
Mark McDonoughDirectorFeb 2023
Pat G. SmerkersDirectorFeb 2023
Aditya G. RajagopalDirectorMar 2022
Carol C. GallagherDirectorMar 2022
James C. BlairDirectorMar 2022
Jenny C. YipDirectorMar 2022
Justin C. KleinDirectorMar 2022
Kevin C. O'BoyleDirectorMar 2022
Pat C. SmerkersDirectorMar 2022
Patrick C. BalthropDirectorMar 2022
Aditya J. RajagopalDirectorDec 2020
Gregory J. GoschDirectorDec 2020
Christopher C. MacGriffDirectorAug 2019
Axel Justin SchererDirectorApr 2017
Peter Justin KleinDirectorApr 2017